Commentary (Buzdar): Optimizing Adjuvant Chemotherapy in Early-Stage Breast Cancer
Aman U. Buzdar
Abstract
Aman U. Buzdar
Abstract
This review of adjuvant chemotherapy by Perez and Muss is concise and complete. For the most part, the authors present the data in a balanced way. The role of adjuvant chemotherapy has been established in breast cancer. Appropriate utilization of adjuvant chemotherapy can significantly reduce the risk of disease recurrence and improve survival. These benefits are associated with adjuvant chemotherapy regardless of the age of the patient, nodal status, or hormonal status of cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This review of adjuvant chemotherapy by Perez and Muss is concise and complete. For the most part, the authors present the data in a balanced way. The role of adjuvant chemotherapy has been established in breast cancer. Appropriate utilization of adjuvant chemotherapy can significantly reduce the risk of disease recurrence and improve survival. These benefits are associated with adjuvant chemotherapy regardless of the age of the patient, nodal status, or hormonal status of cancer.
Key concepts: Medicine, Breast cancer, Adjuvant, Chemotherapy, Adjuvant chemotherapy, Oncology, Stage (stratigraphy), Cancer